5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Dr. Lal Pathlabs Ltd.

•
lalpathlabs.comBSE: 539524NSE: LALPATHLAB
Market Cap₹ 32,049 Cr.
Current Price
High / Low₹ 1,989 / 1,273
Stock P/E59.1
Book Value₹ 156
Price to Book9.01
Dividend Yield1.07 %
ROCE29.6 %
ROE22.4 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 29.7%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 22.9%
  • Company has consistently been profitable over the last 5 years
  • Latest quarter profit grew 27.2% YoY, showing strong momentum
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.28x)

CONS

  • Valuation is stretched - P/E of 59.1 is well above its own 5-year median (26.4)
  • Stock is trading at 9.0x its book value
  • Expensive relative to growth - PEG of 2.1

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcareHospital & Healthcare Services
Part ofNIFTY TOTAL MKTNIFTY SML250 Q50NIFTY SMLCAP 50NIFTY 500NIFTY SMLCAP 250
S.No.Name
1.APOLLOHOSP8850.0060.90127249.420.23610.4038.417043.5020.5621.7315.70
2.MAXHEALTH1037.2069.29100951.740.19322.964.872366.1716.7014.9725.29
3.MANIPALHOS716.15105.5794200.740.002434.30—30906.30—13.9323.83
4.FORTIS887.3063.9366987.440.11272.802.262545.0317.4614.0721.28
5.ASTERDM762.95208.6966504.250.3929.28-68.701310.6821.6011.2619.53
6.MEDANTA1447.5569.9838920.530.03157.25-1.091304.0526.5019.3821.99
7.NH1867.3546.7638161.310.24207.275.372683.6378.0516.2017.43
8.KIMS768.85158.0632292.200.0037.40-56.001179.5035.3311.5119.03
9.LALPATHLAB1909.4059.1432049.051.071705.001172.397977.001090.9529.5631.03
10.AGARWALEYE507.00108.3316073.230.0055.0244.56614.0225.9716.1427.75
11.VIJAYA1502.3082.5315473.350.1353.1037.61230.9822.8330.2842.66
12.RAINBOW1443.4051.3714660.130.2462.5416.23469.9933.1728.2528.65
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
5416015395456026605976036707316607037,977
3954243984014324584434344785064805166,009
Operating Profit1461781411451702031541691922241791871,968
OPM %27.02%29.57%26.09%26.53%28.24%30.67%25.81%28.05%28.71%30.67%27.17%26.58%24.67%
14181818212225262825-624319
Interest88776655557663
Depreciation353636373535363635404245444
Profit before Tax1181521161201501831381531812041241602,287
Tax %28.85%27.27%29.08%28.44%28.09%28.56%29.07%-1.37%26.01%25.25%26.47%17.43%25.45%
Net Profit000010813198156134152911321,705
9.9513.169.7710.1312.7915.525.809.2915.8818.055.427.8610.15

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
9121,0571,2031,3301,5812,0872,0172,2272,4612,76310,070
6757939109871,1451,5271,5271,6171,7661,9807,512
Operating Profit2382642943444365614906096967832,558
OPM %26.03%24.98%24.40%25.83%27.59%26.86%24.29%27.36%28.26%28.32%25.40%
28314655515342699371362
Interest1111516303829222381
Depreciation2833387377108150144142162571
Profit before Tax2372613013113944753445056256692,775
Tax %34.30%34.27%33.30%26.70%24.83%26.25%29.88%28.32%21.21%23.81%25.02%
Net Profit1561722002282963502413624925102,081
EPS18.9520.8224.1527.3735.2541.5728.7442.8558.2830.13—
Dividend Payout %16.12%21.96%25.11%44.27%57.16%29.00%41.89%56.00%41.18%68.05%—

COMPOUNDED SALES GROWTH

10 Years:
13%
5 Years:
12%
3 Years:
11%

COMPOUNDED PROFIT GROWTH

10 Years:
14%
5 Years:
12%
3 Years:
28%

STOCK PRICE CAGR

10 Years:
13%
5 Years:
-2%
3 Years:
20%
1 Year:
16%

RETURN ON EQUITY

10 Years:
24%
5 Years:
22%
3 Years:
23%
Last Year:
22%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2025

Dec 19

1:1

Interim Dividend & Bonus issue & Quarterly Results

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital838383838383838384168
Minority Interest24521313533363433
5046878349171,1221,3601,5251,7152,0322,275
78193110485367103103145
Trade Payables526580118144147156187167181
275265120143199181287211257
Total Liabilities6768991,0691,3511,6332,3102,3452,4112,6303,058
1522082094134471,3691,3051,1941,1351,224
Capital Work in Progress16103106143435
1061451851645965150114327423
18272957435334373644
00000007788111
Cash & Bank240314490569926618665830839910
145196153138152191188155202343
Total Assets6768991,0691,3511,6332,3102,3452,4112,6303,058

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
323291323377500577562535569636
Cash from Investing-137-172-100-26-212-449-287-24-303-422
Cash from Financing-3213-55-190-139136-283-414-334-264
237646748134-11497-68-50

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
54.6053.9253.9153.9153.7953.2153.2153.2153.19
25.4326.8226.8223.9021.6921.8620.2917.1817.35
12.4212.6012.8815.7917.4918.0819.0621.2321.45
0.000.000.000.000.000.000.010.010.01
7.266.376.116.106.746.587.438.357.99

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Copy of Newspaper Publication

2026-09-04 - Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication

2026-08-27
General Updates

2026-08-27 - Dr. Lal Path Labs Ltd. has informed the Exchange about General Updates

2026-08-19
General Updates

2026-08-19 - Incorporation of a Step-Down Subsidiary Company

2026-08-06
ESOP/ESOS/ESPS

2026-08-06 - Dr. Lal Path Labs Ltd. has informed the Exchange regarding Allotment of 211050 Shares.

2026-07-30
Analysts/Institutional Investor Meet/Con. Call Updates

2026-07-30 - Dr. Lal Path Labs Ltd. has informed the Exchange about Transcript

2026-07-26
Change in Director(s)

2026-07-26 - Dr. Lal Path Labs Ltd. has informed the Exchange regarding Change in Director(s) of the company.

2026-07-25
Shareholders meeting

2026-07-25 - Dr. Lal Path Labs Ltd. has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 25, 2026. Further, the company has informed the Exchange regarding voting results.

2026-07-25
Shareholders meeting

2026-07-25 - Dr. Lal Path Labs Ltd. has informed the Exchange regarding Proceedings of Annual General Meeting held on July 25, 2026

2026-07-25
Copy of Newspaper Publication

2026-07-25 - Dr. Lal Path Labs Ltd. has informed the Exchange about Copy of Newspaper Publication

News

Recent coverage and analyst commentary for LALPATHLAB

Loading news…

🤖

AI Stock Analyst

Dr. Lal Pathlabs Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login